BLE1_PSEAI
ID BLE1_PSEAI Reviewed; 308 AA.
AC P37321;
DT 01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-1994, sequence version 1.
DT 03-AUG-2022, entry version 94.
DE RecName: Full=Extended-spectrum beta-lactamase PER-1;
DE EC=3.5.2.6;
DE Flags: Precursor;
GN Name=per1;
OS Pseudomonas aeruginosa.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC Pseudomonadaceae; Pseudomonas.
OX NCBI_TaxID=287;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC STRAIN=RNL-1;
RX PubMed=8141562; DOI=10.1128/aac.38.1.104;
RA Nordmann P., Naas T.;
RT "Sequence analysis of PER-1 extended-spectrum beta-lactamase from
RT Pseudomonas aeruginosa and comparison with class A beta-lactamases.";
RL Antimicrob. Agents Chemother. 38:104-114(1994).
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a beta-lactam + H2O = a substituted beta-amino acid;
CC Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627,
CC ChEBI:CHEBI:140347; EC=3.5.2.6; Evidence={ECO:0000255|PROSITE-
CC ProRule:PRU10101};
CC -!- SIMILARITY: Belongs to the class-A beta-lactamase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; Z21957; CAA79968.1; -; Genomic_DNA.
DR PIR; S35931; S35931.
DR RefSeq; WP_001100753.1; NZ_RXTL01000078.1.
DR PDB; 1E25; X-ray; 1.90 A; A=27-308.
DR PDBsum; 1E25; -.
DR AlphaFoldDB; P37321; -.
DR SMR; P37321; -.
DR DrugBank; DB09060; Avibactam.
DR KEGG; ag:CAA79968; -.
DR SABIO-RK; P37321; -.
DR EvolutionaryTrace; P37321; -.
DR GO; GO:0008800; F:beta-lactamase activity; IEA:UniProtKB-EC.
DR GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR Gene3D; 3.40.710.10; -; 1.
DR InterPro; IPR012338; Beta-lactam/transpept-like.
DR InterPro; IPR045155; Beta-lactam_cat.
DR InterPro; IPR000871; Beta-lactam_class-A.
DR InterPro; IPR023650; Beta-lactam_class-A_AS.
DR PANTHER; PTHR35333; PTHR35333; 1.
DR Pfam; PF13354; Beta-lactamase2; 1.
DR PRINTS; PR00118; BLACTAMASEA.
DR SUPFAM; SSF56601; SSF56601; 1.
DR PROSITE; PS00146; BETA_LACTAMASE_A; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Antibiotic resistance; Direct protein sequencing; Hydrolase;
KW Signal.
FT SIGNAL 1..26
FT CHAIN 27..308
FT /note="Extended-spectrum beta-lactamase PER-1"
FT /id="PRO_0000017042"
FT ACT_SITE 71
FT /note="Acyl-ester intermediate"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10101"
FT BINDING 239..241
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT HELIX 29..39
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 42..51
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 59..62
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 70..72
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 73..86
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 95..99
FT /evidence="ECO:0007829|PDB:1E25"
FT TURN 100..102
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 111..114
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 117..123
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 124..134
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 137..147
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 149..159
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 171..176
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 180..183
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 184..186
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 188..199
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 206..217
FT /evidence="ECO:0007829|PDB:1E25"
FT TURN 226..229
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 236..242
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 249..260
FT /evidence="ECO:0007829|PDB:1E25"
FT STRAND 266..276
FT /evidence="ECO:0007829|PDB:1E25"
FT HELIX 280..304
FT /evidence="ECO:0007829|PDB:1E25"
SQ SEQUENCE 308 AA; 33573 MW; CED838DFC7D6E117 CRC64;
MNVIIKAVVT ASTLLMVSFS SFETSAQSPL LKEQIESIVI GKKATVGVAV WGPDDLEPLL
INPFEKFPMQ SVFKLHLAML VLHQVDQGKL DLNQTVIVNR AKVLQNTWAP IMKAYQGDEF
SVPVQQLLQY SVSHSDNVAC DLLFELVGGP AALHDYIQSM GIKETAVVAN EAQMHADDQV
QYQNWTSMKG AAEILKKFEQ KTQLSETSQA LLWKWMVETT TGPERLKGLL PAGTVVAHKT
GTSGIKAGKT AATNDLGIIL LPDGRPLLVA VFVKDSAESS RTNEAIIAQV AQTAYQFELK
KLSALSPN